Live Breaking News & Updates on Han van egmond

Stay informed with the latest breaking news from Han van egmond on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Han van egmond and stay connected to the pulse of your community

Recipharm and Medspray Launch Resyca Joint Venture to Exploit Novel Softmist Technology for Pharmaceutical Applications

Recipharm and Medspray Launch Resyca Joint Venture to Exploit Novel Softmist Technology for Pharmaceutical Applications
Monday, 01 February 2021 18:00
Hits: 6982

ENSCHEDE, the Netherlands, February 01, 2021 / B3C newswire / --Recipharm AB (publ) (“Recipharm”), a leading contract development and manufacturing organisation (CDMO) and Medspray BV (“Medspray”), a manufacturer of high tech spray nozzles, announce that they have now completed the previously announced joint venture and established Resyca BV. Resyca will develop and exploit the softmist spray nozzle technology for pharmaceutical applications. This has the potential to eliminate the need for propellants by delivering therapies deep into the lungs more effectively with lower doses as less ends up in the mouth and throat.

Germany , India , Stockholm , Sweden , Munich , Bayern , Netherlands , United-kingdom , Israel , Enschede , Overijssel , Italy

Recipharm and Medspray Launch Resyca Joint Venture to Exploit Novel Softmist Technology for Pharmace

Recipharm and Medspray Launch Resyca Joint Venture to Exploit Novel Softmist Technology for Pharmaceutical Applications

ENSCHEDE, the Netherlands, February 01, 2021 / B3C newswire / --Recipharm AB (publ) (“Recipharm”), a leading contract development and manufacturing organisation (CDMO) and Medspray BV (“Medspray”), a manufacturer of high tech spray nozzles, announce that they have now completed the previously announced joint venture and established Resyca BV. Resyca will develop and exploit the softmist spray nozzle technology for pharmaceutical applications. This has the potential to eliminate the need for propellants by delivering therapies deep into the lungs more effectively with lower doses as less ends up in the mouth and throat.

Germany , India , Stockholm , Sweden , Munich , Bayern , Netherlands , United-kingdom , Israel , Enschede , Overijssel , Italy